Skip to main content

Table 7 Multivariable logistic regressive analysis: risk factors for flare

From: Treatments and outcomes in Chinese patients with serologically active clinically quiescent systemic lupus erythematosus: a retrospective observational study

  β p OR (95% CI)
SACQ patients 0.936 0.001 2.550 (1.478, 4.400)
Dose of corticosteroidsa (mg) when relapsed or at the end of follow-up − 1.422 < 0.001 1.239 (1.102, 1.3914)
Taking antimalarials when relapsed or at the end of follow-up − 1.039 < 0.001 0.241 (0.132, 0.442)
Taking immunosuppressants when relapsed or at the end of follow-up − 0.945 < 0.001 0.354 (0.202, 0.619)
  1. In both SACQ and SQCQ patients (85 patients). Variables included in the model: SACQ patients or not, age at diagnosis (years), dose of corticosteroids (mg) when relapsed or at the end of follow-up, taking antimalarials when relapsed or at the end of follow-up, taking immunosuppressants when relapsed or at the end of follow-up
  2. aCorticosteroid doses were converted to milligrams (mg) of prednisone equivalent